This message contains images. If you don't see images, click here to view.
Advertise in this news brief.
|
|
|
|
CAP '14 Annual Meeting: Sept. 7-10, Chicago, Illinois
FSP 2015 Annual Anatomic Pathology Conference: Feb. 13-15, 2015
The FSP Summer Anatomic Pathology Conference held July 13 and 14, 2014 was a tremendous success. We heard sensational talks from Geza Acs, M.D., PhD, Teri A. Longacre, M.D. and Bruce Smoller, M.D. Thank you for sharing your knowledge with us! The attendees enjoyed the science and the social networking as well as the learning in the Exhibit Hall with our partners. A special thanks to our Platinum Sponsor: NeoGenomics Laboratories and Vitro Molecular Laboratories who contributed as well! Thank you! Thanks also go to our vendors.
READ MORE
|
Gov. Scott: Fee reductions for healthcare professionals
Florida Governor's Press Office
Governor Rick Scott announced fee reductions for the licensing of certain healthcare professionals. Due to efficiencies found and the streamlining of processes, both the Florida Board of Medicine and Florida Board of Nursing identified excess fees and are passing this on as a cost savings to licensees.
FDA acts on lab tests developed in-house
The New York Times
The Food and Drug Administration announced it would start regulating medical laboratory testing, saying that tests used to make important treatment decisions must be vetted and validated before they go into use. The decision, long in coming, has been fiercely opposed by some laboratories and pathologists, who have said that regulation by the agency is unnecessary and would significantly increase the cost and time needed to develop tests, stifling innovation and depriving patients of some vital tools.
College of American Pathologists files formal complaint with CMS about Palmetto GBA
The Pathology Blawg
The College of American Pathologists has filed a formal complaint with the Centers of Medicare and Medicaid Services about the recent attempts by Medicare Administrative Contractor Palmetto GBA to tamp down pathology fraud. The complaint focuses on an educational article about appropriate utilization of ancillary stains for gastric biopsies that Palmetto posted on its website on May 30, 2014.
Jury finds oncologist negligent for withholding crucial information from pathologist
The Pathology Blawg
A Massachusetts jury found an oncologist was negligent when he failed to provide pertinent clinical information to a hematopathologist that may have prevented an erroneous diagnosis of non-Hodgkin lymphoma in a patient who subsequently died from treatment complications.
Genetic biomarker predicted tamoxifen resistance in ER-positive breast cancer
Healio
Loss of function in the deubiquitinase USP9X appears to be associated with resistance to tamoxifen in patients with ER alpha-positive breast cancer, according to study findings. The results suggest this gene signature may help predict how patients will respond to the drug, researchers wrote.
Biomarker for head and neck cancers identified
News-Medical
Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.
Clinical labs, pathology groups to collecting full payment at time of service
Dark Daily
Due to a need to collect payment directly from the growing number of patients with high-deductible health plans, many clinical laboratories and anatomic pathology groups are experiencing flat or even declining cash flow. This issue has medical lab CFOs scrambling to find solutions. Moreover, this problem is noticeably greater in 2014 than it was in 2013. One factor behind this worrisome trend is the Affordable Care Act.
Pancreatic cancer study finds new genetic risk markers
Medical News Today
After comparing the DNA of thousands of people with and without the disease, a new study has identified five genetic markers for pancreatic cancer that raise the risk for developing the deadly disease. The international consortium of scientists reports the findings in the journal Nature Genetics. The discovery is the result of a third project in a series of genome-wide association studies that began in 2006 under the auspices of the National Cancer Institute Cohort Consortium.
Disclaimer: The authors, editors, and the Florida Society of Pathologists (FSP) Executive Committee affiliated with "Florida Pathology Today" e-Newsletter cannot and do not warrant the completeness, accuracy, non-infringement, merchantability, timeliness or fitness for a particular purpose of the information or views contained within this publication, or available through the links provided within articles contained within this publication.
FSP has no control over and does not officially endorse the content of the information available on the links contained in the "Florida Pathology Today" or links imbedded in articles within the "Florida Pathology Today." These links are provided as a courtesy only. Linked sites are not a part of the "Florida Pathology Today." The owners of those linked sites, and not FSP, own the intellectual property rights to the material on the linked sites. FSP cannot certify the accuracy of material published on linked sites. Additionally, the contents of this e-Newsletter and the above referenced links, including any advice, suggestions, and/or recommendations have NOT been generated as part of any professional evaluation.
The authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" e-Newsletter shall not be liable to anyone for any loss or injury caused in whole or in part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting or delivering this e-Newsletter and any information included in this e-Newsletter.
Under no circumstances will the authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" be liable to you or anyone else for any decision made or any action taken by you or anyone else in reliance on such information or view, or for any incidental, consequential, special, or similar damages even if advised of the possibility of such damages.
The above warranties are the only warranties of any kind either expressed or implied, including warranties of merchantability or fitness for any particular purpose.
|
|
| |
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
